Pacira BioSciences, Inc.
US ˙ NasdaqGS ˙ US6951271005

SecurityPCRX / Pacira BioSciences, Inc.
InstitutionJanus Henderson Group Plc
Latest Disclosed Ownership23,319 shares
Latest Disclosed Value $ 526,776
Janus Henderson Group Plc ownership in PCRX / Pacira BioSciences, Inc.

On May 18, 2026 - Janus Henderson Group Plc filed a 13F-HR/A form disclosing ownership of 23,319 shares of Pacira BioSciences, Inc. (US:PCRX) valued at $527,009 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 23,319 shares of Pacira BioSciences, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $530,507 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-18 2026-03-31 13F/A-1 PACIRA BIOSCIENCES COM 695127100 23,319 0 0.00 527 -12.77 0.0001
2026-05-15 2026-03-31 13F PACIRA BIOSCIENCES COM 695127100 23,319 0 0.00 527 -12.77 0.0001
2026-02-17 2025-12-31 13F PACIRA BIOSCIENCES COM 695127100 23,319 0 0.00 603 0.33 0.0003
2025-11-14 2025-09-30 13F PACIRA BIOSCIENCES COM 695127100 23,319 0 0.00 601 7.90 0.0003
2025-08-14 2025-06-30 13F PACIRA BIOSCIENCES COM 695127100 23,319 0 0.00 557 -3.97 0.0003
2025-05-15 2025-03-31 13F PACIRA BIOSCIENCES COM 695127100 23,319 0 0.00 581 32.12 0.0003
2025-02-14 2024-12-31 13F PACIRA BIOSCIENCES COM 695127100 23,319 0 0.00 439 25.07 0.0002
2024-11-14 2024-09-30 13F PACIRA BIOSCIENCES COM 695127100 23,319 -675,069 -96.66 351 -98.24 0.0002
2024-08-14 2024-06-30 13F PACIRA BIOSCIENCES COM 695127100 698,388 96,328 16.00 19,981 13.58 0.0107
2024-05-15 2024-03-31 13F PACIRA BIOSCIENCES COM 695127100 602,060 -1,973 -0.33 17,592 -13.68 0.0096
2024-02-14 2023-12-31 13F PACIRA BIOSCIENCES COM 695127100 604,033 66,330 12.34 20,380 23.55 0.0122
2023-11-14 2023-09-30 13F PACIRA BIOSCIENCES COM 695127100 537,703 183,604 51.85 16,496 16.27 0.0108
2023-08-14 2023-06-30 13F PACIRA BIOSCIENCES COM 695127100 354,099 334,292 1,687.75 14,188 1,658.12 0.0088
2023-05-15 2023-03-31 13F PACIRA BIOSCIENCES COM 695127100 19,807 10,976 124.29 808 137.35 0.0005
2023-02-14 2022-12-31 13F PACIRA BIOSCIENCES COM 695127100 8,831 1 0.01 341 -27.66 0.0002
2022-11-14 2022-09-30 13F PACIRA BIOSCIENCES COM 695127100 8,830 16 0.18 470 -8.56 0.0004
2022-08-15 2022-06-30 13F PACIRA BIOSCIENCES COM 695127100 8,814 -9 -0.10 514 -23.74 0.0004
2022-05-16 2022-03-31 13F PACIRA BIOSCIENCES COM 695127100 8,823 -30,842 -77.76 674 -71.75 0.0003
2022-02-14 2021-12-31 13F PACIRA BIOSCIENCES COM 695127100 39,665 -22,278 -35.97 2,386 -31.22 0.0010
2021-11-16 2021-09-30 13F PACIRA BIOSCIENCES COM 695127100 61,943 -10,391 -14.37 3,469 -20.96 0.0015
2021-08-16 2021-06-30 13F PACIRA BIOSCIENCES COM 695127100 72,334 -4,981 -6.44 4,389 -19.01 0.0019
2021-05-17 2021-03-31 13F PACIRA BIOSCIENCES COM 695127100 77,315 77,315 5,419 0.0025
2016-05-12 2016-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 0 -159,210 -100.00 0 -100.00
2016-02-03 2015-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 159,210 25,708 19.26 12,229 122.83 0.0981
2015-11-16 2015-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 133,502 25,990 24.17 5,488 -27.83 0.0483
2015-08-17 2015-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 107,512 9,612 9.82 7,604 -12.56 0.0598
2015-06-02 2015-03-31 13F/A-1 PACIRA PHARMACEUTICALS COM 695127100 97,900 32,430 49.53 8,696 49.80 0.0671
2015-05-15 2015-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 97,900 8,696
2015-02-12 2014-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 65,470 11,578 21.48 5,805 11.14 0.0419
2014-11-12 2014-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 53,892 53,892 5,223 0.0491
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.